Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AVXL — Anavex Life Sciences Corp.

CIK 1446194 BALA CYNWYD, PA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$827,580
-$2,229,105 QoQ
Shares Held
319,529
-67.9% QoQ
Ownership
0.345%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Derivatives in AVXL

reported options exposure · as of Jun 30, 2026
CallValue
$33,411
CallShares
12,900
PutValue
$355,348
PutShares
137,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. AVXL ranks #134 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in AVXL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,411 12,900
2026-06-30 $355,348 137,200
2026-06-30 $827,580 319,529
2026-03-31 $735,265 239,500
2026-03-31 $3,056,685 995,663
2026-03-31 $934,508 304,400
2025-12-31 $1,564,616 439,499
2025-12-31 $2,053,052 576,700
2025-12-31 $1,297,620 364,500
2025-09-30 $5,373,980 603,818
2025-09-30 $5,283,040 593,600
2025-09-30 $6,206,860 697,400
2025-06-30 $2,220,176 240,800
2025-06-30 $2,683,020 291,000
2025-06-30 $5,593,469 606,667
2025-03-31 $3,325,608 387,600
2025-03-31 $1,619,904 188,800
2025-03-31 $6,753,318 787,100
2024-12-31 $2,984,646 277,900
2024-12-31 $12,187,086 1,134,738
2024-12-31 $2,294,064 213,600
2024-09-30 $1,100,784 193,800
2024-09-30 $1,354,208 238,417
2024-09-30 $1,071,248 188,600
2024-06-30 $1,115,915 264,435
2024-06-30 $513,152 121,600
2024-06-30 $1,136,024 269,200
2024-03-31 $1,327,472 260,800
2024-03-31 $1,777,937 349,300
2024-03-31 $1,537,485 302,060
2023-12-31 $6,715,796 721,353
2023-12-31 $2,718,520 292,000
2023-12-31 $6,035,673 648,300
2023-09-30 $3,888,735 593,700
2023-09-30 $3,196,400 488,000
2023-09-30 $2,920,729 445,913
2023-06-30 $5,151,485 633,639
2023-06-30 $2,697,534 331,800
2023-06-30 $3,601,590 443,000
2023-03-31 $5,217,364 608,794
2023-03-31 $4,278,144 499,200
2023-03-31 $5,690,480 664,000
2022-12-31 $3,471,462 374,888
2022-12-31 $4,266,082 460,700
2022-12-31 $6,354,212 686,200
2022-09-30 $3,739,110 362,317
2022-09-30 $6,284,880 609,000
2022-09-30 $5,374,656 520,800
2022-06-30 $5,233,228 522,800
2022-06-30 $4,725,721 472,100